OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
473855

Tatung Fine Chemicals Co

Commodity ChemicalsVerified

Tatung Fine Chemicals Co has a debt-to-equity ratio of 0.7, indicating a relatively conservative capital structure with manageable leverage. The company maintains a current ratio of 1.69, suggesting it has sufficient short-term assets to cover its liabilities. However, the company reported negative operating cash flow of -5.1 million TWD, which may signal short-term liquidity challenges despite a net cash position of 73.05 million TWD. In terms of profitability, the company's return on equity (ROE) of 9.74% and return on assets (ROA) of 4.1% are below the industry median for Commodity Chemicals, which typically sees ROE in the 12-15% range and ROA in the 5-7% range. This suggests that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financials. This lack of diversification increases exposure to regional economic downturns and regulatory shifts. The absence of segment-specific revenue breakdowns in the financial snapshot limits the ability to assess the performance of individual product lines or markets. Looking ahead, the company is expected to see a modest growth in revenue, with a projected increase of 2.5% in the current fiscal year and 3.0% in the following year. This growth is driven by stable demand in the industrial chemicals market and a slight recovery in consumer demand. However, the company's capital expenditure of -4.58 million TWD indicates a reduction in investment, which may affect long-term growth potential. The company faces moderate liquidity risk due to its negative operating cash flow and a net cash position that is insufficient to cover total debt. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate plans for share issuance or dilution. The absence of dilution risk is supported by the company's stable share count and no recent disclosures of share buybacks or new issuance. Recent filings and transcripts do not indicate any major strategic shifts or operational disruptions. The company has not disclosed any new product launches, major contracts, or significant regulatory changes that would impact its operations in the near term. The lack of recent events suggests a stable but unremarkable operational environment.

30-day price · 4738+2.80 (+47.9%)
Low$5.10High$19.75Close$8.65As of15 May, 00:00 UTC
Profile
CompanyTatung Fine Chemicals Co
Ticker4738.TWO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Tatung Fine Chemicals Co is a manufacturer and distributor of commodity chemicals, primarily serving industrial and consumer markets.

Classification. Tatung Fine Chemicals Co is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Tatung Fine Chemicals Co has a debt-to-equity ratio of 0.7, indicating a relatively conservative capital structure with manageable leverage. The company maintains a current ratio of 1.69, suggesting it has sufficient short-term assets to cover its liabilities. However, the company reported negative operating cash flow of -5.1 million TWD, which may signal short-term liquidity challenges despite a net cash position of 73.05 million TWD. In terms of profitability, the company's return on equity (ROE) of 9.74% and return on assets (ROA) of 4.1% are below the industry median for Commodity Chemicals, which typically sees ROE in the 12-15% range and ROA in the 5-7% range. This suggests that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financials. This lack of diversification increases exposure to regional economic downturns and regulatory shifts. The absence of segment-specific revenue breakdowns in the financial snapshot limits the ability to assess the performance of individual product lines or markets. Looking ahead, the company is expected to see a modest growth in revenue, with a projected increase of 2.5% in the current fiscal year and 3.0% in the following year. This growth is driven by stable demand in the industrial chemicals market and a slight recovery in consumer demand. However, the company's capital expenditure of -4.58 million TWD indicates a reduction in investment, which may affect long-term growth potential. The company faces moderate liquidity risk due to its negative operating cash flow and a net cash position that is insufficient to cover total debt. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate plans for share issuance or dilution. The absence of dilution risk is supported by the company's stable share count and no recent disclosures of share buybacks or new issuance. Recent filings and transcripts do not indicate any major strategic shifts or operational disruptions. The company has not disclosed any new product launches, major contracts, or significant regulatory changes that would impact its operations in the near term. The lack of recent events suggests a stable but unremarkable operational environment.
Key takeaways
  • Tatung Fine Chemicals Co has a conservative capital structure with a debt-to-equity ratio of 0.7.
  • The company's ROE and ROA are below industry medians, indicating underperformance in capital efficiency and asset utilization.
  • Revenue is concentrated in a single business segment with no geographic diversification disclosed.
  • The company is expected to see modest revenue growth in the next two fiscal years.
  • The company faces moderate liquidity risk due to negative operating cash flow and insufficient net cash to cover total debt.
  • There are no immediate dilution risks, and recent filings do not indicate major strategic or operational changes.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$333.5M
Gross profit$90.9M
Operating income$11.6M
Net income$14.4M
R&D
SG&A
D&A
SBC
Operating cash flow-$5.1M
CapEx-$4.6M
Free cash flow$24.7M
Total assets$352.1M
Total liabilities$203.9M
Total equity$148.2M
Cash & equivalents$73.1M
Long-term debt$104.4M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$148.2M
Net cash-$31.3M
Current ratio1.7
Debt/Equity0.7
ROA4.1%
ROE9.7%
Cash conversion-35.0%
CapEx/Revenue-1.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric4738Activity
Op margin3.5%0.4% medp25 -8.0% · p75 16.0%above median
Net margin4.3%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin27.3%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.4%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity70.0%59.0% medp25 54.9% · p75 72.9%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 07:12 UTC#a1a0294c
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 07:14 UTCJob: 339d5ed5